Electronic health records
...tools in clinical trials” published on 12 August 2010 look for any eclinical advice and tools online - we cannot recommend any particular product or assessment as this will vary...
...tools in clinical trials” published on 12 August 2010 look for any eclinical advice and tools online - we cannot recommend any particular product or assessment as this will vary...
...you will see online. It helps those participating to identify who they are talking to and build professional relationships. Welcome to the MHRA Blood Forum and happy posting. Medical test-tube...
...in 2014 with further guidance and examples of remote monitoring. In 2020]}** this risk-adapted approach also featured in our guidance around COVID-19 flexibilities, and organisations have been asking if we...
...pharmaceutical industry. For an overview of unlicensed Cannabis-Based Products for Medicinal use (unlicensed CBPMs), please see the following guidance which was updated in March 2020]}**: “The supply, manufacture, importation and...
In the October blog post we told you about the successful audit of the GMP Inspectorate under the JAP programme. Later that month the entire Inspectorate was assessed as part...
https://youtu.be/AGTitnGny50 Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020]}**. This webinar was part of a series of Brexit and post-transition guidance webinars....
...in member states. In the UK this is currently the SI 2004/1031 (as amended). It is important to note that although the transition period ended on 31 December 2020]}**, the...
...London in February 2020]}**, covering international collaboration, sponsor oversight, electronic source documents, protocol deviations and data quality in novel clinical trial designs. MHRA hope to publish a further paper jointly...
...regulatory inspection programmes necessary to protect public health. On 20th March 2020]}** MHRA announced a risk-based prioritisation of Good Practice inspections due to the COVID19 outbreak. Until further notice, MHRA...
...miss the next joint MHRA/FDA GCP symposium with a commercial focus on 13 and 14 February 2020]}**. Registration details can be found here. Don’t miss the next post, sign...